Yuliya Lokhnygina, Ph.D. - Publications

Affiliations: 
2004 North Carolina State University, Raleigh, NC 
Area:
Statistics

83 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Shah R, Hellkamp A, Lokhnygina Y, Becker RC, Berkowitz SD, Breithardt G, Hacke W, Halperin JL, Hankey GJ, Fox KA, Nessel CC, Mahaffey KW, Piccini JP, Singer DE, Patel MR, et al. Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial. American Heart Journal. 179: 77-86. PMID 27595682 DOI: 10.1016/j.ahj.2016.05.019  1
2016 Åkerblom A, Clare RM, Lokhnygina Y, Wallentin L, Held C, Van de Werf F, Moliterno DJ, Patel UD, Leonardi S, Armstrong PW, Harrington RA, White HD, Aylward PE, Mahaffey KW, Tricoci P. Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial. American Heart Journal. 178: 1-8. PMID 27502846 DOI: 10.1016/j.ahj.2016.04.013  1
2016 Fordyce CB, Hellkamp AS, Lokhnygina Y, Lindner SM, Piccini JP, Becker RC, Berkowitz SD, Breithardt G, Fox KA, Mahaffey KW, Nessel CC, Singer DE, Patel MR. On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF. Circulation. 134: 37-47. PMID 27358435 DOI: 10.1161/CIRCULATIONAHA.116.021890  1
2016 Breithardt G, Baumgartner H, Berkowitz SD, Hellkamp AS, Piccini JP, Lokhnygina Y, Halperin JL, Singer DE, Hankey GJ, Hacke W, Becker RC, Nessel CC, Mahaffey KW, Califf RM, Fox KA, et al. Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban. Heart (British Cardiac Society). PMID 26888572 DOI: 10.1136/heartjnl-2015-308120  1
2016 Farber SH, Hatef J, Han JL, Marky AH, Xie J, Huang K, Verla T, Lokhnygina Y, Collins TA, Lad SP. Implantable Neurostimulation for Headache Disorders: Effect on Healthcare Utilization and Expenditures. Neuromodulation : Journal of the International Neuromodulation Society. PMID 26857099 DOI: 10.1111/ner.12393  1
2016 Murphy SA, Cannon CP, Blazing MA, Giugliano RP, White JA, Lokhnygina Y, Reist C, Im K, Bohula EA, Isaza D, Lopez-Sendon J, Dellborg M, Kher U, Tershakovec AM, Braunwald E. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial. Journal of the American College of Cardiology. 67: 353-61. PMID 26821621 DOI: 10.1016/j.jacc.2015.10.077  1
2015 Li F, Lokhnygina Y, Murray DM, Heagerty PJ, DeLong ER. An evaluation of constrained randomization for the design and analysis of group-randomized trials. Statistics in Medicine. PMID 26598212 DOI: 10.1002/sim.6813  1
2015 Halim SA, Clare RM, Newby LK, Lokhnygina Y, Schweiger MJ, Hof AW, Hochman JS, James SK, White HD, Widimsky P, Betriu A, Bode C, Giugliano RP, Harrington RA, Zeymer U. Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesions. International Journal of Cardiology. 203: 708-713. PMID 26587725 DOI: 10.1016/j.ijcard.2015.11.036  1
2015 Daneshmand MA, Krishnamoorthy A, Samsky MD, Felker GM, Pura JA, Lokhnygina Y, Hernandez AF, Rosenberg PB, Blue LJ, Schroder JN, Rogers JG, Milano CA, Patel CB. Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow. The American Journal of Cardiology. PMID 26092273 DOI: 10.1016/j.amjcard.2015.05.016  1
2015 Bagai A, Huang Z, Lokhnygina Y, Harrington RA, Armstrong PW, Strony J, White HD, Leonardi S, Held C, Van de Werf F, Wallentin L, Tricoci P, Mahaffey KW. Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization. Circulation. Cardiovascular Interventions. 8: e002314. PMID 26025218 DOI: 10.1161/CIRCINTERVENTIONS.115.002314  1
2015 Cornel JH, Tricoci P, Lokhnygina Y, Moliterno DJ, Wallentin L, Armstrong PW, Aylward PE, Clare RM, Chen E, Leonardi S, Van de Werf F, White HD, Held C, Strony J, Mahaffey KW, et al. Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial). The American Journal of Cardiology. 115: 1325-32. PMID 25776457 DOI: 10.1016/j.amjcard.2015.02.043  1
2015 Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breithardt G, Singer DE, Mahaffey KW, Hankey GJ, Berkowitz SD, Nessel CC, Fox KA, Califf RM, Piccini JP, Patel MR. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Lancet (London, England). 385: 2363-70. PMID 25749644 DOI: 10.1016/S0140-6736(14)61836-5  1
2015 Verla T, Marky A, Farber H, Petraglia FW, Gallis J, Lokhnygina Y, Parente B, Hickey P, Turner DA, Lad SP. Impact of advancing age on post-operative complications of deep brain stimulation surgery for essential tremor. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 22: 872-6. PMID 25669119 DOI: 10.1016/j.jocn.2014.11.005  1
2015 Ahmad T, Wang T, O'Brien EC, Samsky MD, Pura JA, Lokhnygina Y, Rogers JG, Hernandez AF, Craig D, Bowles DE, Milano CA, Shah SH, Januzzi JL, Felker GM, Patel CB. Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury. Jacc. Heart Failure. 3: 30-9. PMID 25447345 DOI: 10.1016/j.jchf.2014.06.013  1
2015 Steinberg BA, Hellkamp AS, Lokhnygina Y, Patel MR, Breithardt G, Hankey GJ, Becker RC, Singer DE, Halperin JL, Hacke W, Nessel CC, Berkowitz SD, Mahaffey KW, Fox KA, Califf RM, et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. European Heart Journal. 36: 288-96. PMID 25209598 DOI: 10.1093/eurheartj/ehu359  1
2015 Bakal JA, Roe MT, Ohman EM, Goodman SG, Fox KA, Zheng Y, Westerhout CM, Hochman JS, Lokhnygina Y, Brown EB, Armstrong PW. Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial. European Heart Journal. 36: 385-92a. PMID 25012156 DOI: 10.1093/eurheartj/ehu262  1
2015 Bansilal S, Bloomgarden Z, Halperin JL, Hellkamp AS, Lokhnygina Y, Patel MR, Becker RC, Breithardt G, Hacke W, Hankey GJ, Nessel CC, Singer DE, Berkowitz SD, Piccini JP, Mahaffey KW, et al. Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial) American Heart Journal. DOI: 10.1016/j.ahj.2015.07.006  1
2015 Wieslander B, Nijveldt R, Klem I, Lokhnygina Y, Pura J, Wagner GS, Ugander M, Atwater BD. Evaluation of Selvester QRS score for use in presence of conduction abnormalities in a broad population American Heart Journal. DOI: 10.1016/j.ahj.2015.05.005  1
2014 Allen LaPointe NM, Lokhnygina Y, Rimmler J, Sanders GD, Peterson ED, Al-Khatib SM. Use Of Rate And Rhythm Control Drugs In Patients Younger Than 65 Years With Atrial Fibrillation. Journal of Atrial Fibrillation. 7: 22-30. PMID 25530826  1
2014 Tricoci P, Lokhnygina Y, Huang Z, Van de Werf F, Cornel JH, Chen E, Wallentin L, Held C, Aylward PE, Moliterno DJ, Jennings LK, White HD, Armstrong PW, Harrington RA, Strony J, et al. Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial. American Heart Journal. 168: 869-77.e1. PMID 25458650 DOI: 10.1016/j.ahj.2014.09.002  1
2014 DeLong MR, Huang KT, Gallis J, Lokhnygina Y, Parente B, Hickey P, Turner DA, Lad SP. Effect of advancing age on outcomes of deep brain stimulation for Parkinson disease. Jama Neurology. 71: 1290-5. PMID 25155481 DOI: 10.1001/jamaneurol.2014.1272  1
2014 Breithardt G, Baumgartner H, Berkowitz SD, Hellkamp AS, Piccini JP, Stevens SR, Lokhnygina Y, Patel MR, Halperin JL, Singer DE, Hankey GJ, Hacke W, Becker RC, Nessel CC, Mahaffey KW, et al. Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. European Heart Journal. 35: 3377-85. PMID 25148838 DOI: 10.1093/eurheartj/ehu305  1
2014 Piccini JP, Al-Khatib SM, Wojdyla DM, Shaw LK, Horton JR, Lokhnygina Y, Anstrom KJ, DeWald T, Allen-LaPointe N, Steinberg BA, Thomas K, Daubert JP, Peterson ED. Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease. The American Journal of Cardiology. 114: 716-22. PMID 25129065 DOI: 10.1016/j.amjcard.2014.06.004  1
2014 Valgimigli M, Tricoci P, Huang Z, Aylward PE, Armstrong PW, Van de Werf F, Leonardi S, White HD, Widimsky P, Harrington RA, Cequier A, Chen E, Lokhnygina Y, Wallentin L, Strony J, et al. Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial). The American Journal of Cardiology. 114: 665-73. PMID 25129064 DOI: 10.1016/j.amjcard.2014.05.054  1
2014 White HD, Huang Z, Tricoci P, Van de Werf F, Wallentin L, Lokhnygina Y, Moliterno DJ, Aylward PE, Mahaffey KW, Armstrong PW. Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER. Journal of the American Heart Association. 3. PMID 25012288 DOI: 10.1161/JAHA.114.001032  1
2014 Babu R, Thomas S, Hazzard MA, Lokhnygina YV, Friedman AH, Gottfried ON, Isaacs RE, Boakye M, Patil CG, Bagley CA, Haglund MM, Lad SP. Morbidity, mortality, and health care costs for patients undergoing spine surgery following the ACGME resident duty-hour reform: Clinical article. Journal of Neurosurgery. Spine. 21: 502-15. PMID 24995600 DOI: 10.3171/2014.5.SPINE13283  1
2014 Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA, et al. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Circulation. 130: 138-46. PMID 24895454 DOI: 10.1161/CIRCULATIONAHA.113.005008  1
2014 Ilowite NT, Prather K, Lokhnygina Y, Schanberg LE, Elder M, Milojevic D, Verbsky JW, Spalding SJ, Kimura Y, Imundo LF, Punaro MG, Sherry DD, Tarvin SE, Zemel LS, Birmingham JD, et al. Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis. Arthritis & Rheumatology (Hoboken, N.J.). 66: 2570-9. PMID 24839206 DOI: 10.1002/art.38699  1
2014 Steinberg BA, Hellkamp AS, Lokhnygina Y, Halperin JL, Breithardt G, Passman R, Hankey GJ, Patel MR, Becker RC, Singer DE, Hacke W, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, et al. Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 11: 925-32. PMID 24833235 DOI: 10.1016/j.hrthm.2014.03.006  1
2014 Piccini JP, Hellkamp AS, Lokhnygina Y, Patel MR, Harrell FE, Singer DE, Becker RC, Breithardt G, Halperin JL, Hankey GJ, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM, et al. Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial. Journal of the American Heart Association. 3: e000521. PMID 24755148 DOI: 10.1161/JAHA.113.000521  1
2014 Hankey GJ, Stevens SR, Piccini JP, Lokhnygina Y, Mahaffey KW, Halperin JL, Patel MR, Breithardt G, Singer DE, Becker RC, Berkowitz SD, Paolini JF, Nessel CC, Hacke W, Fox KA, et al. Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Stroke; a Journal of Cerebral Circulation. 45: 1304-12. PMID 24743444 DOI: 10.1161/STROKEAHA.113.004506  1
2014 Piccini JP, Garg J, Patel MR, Lokhnygina Y, Goodman SG, Becker RC, Berkowitz SD, Breithardt G, Hacke W, Halperin JL, Hankey GJ, Nessel CC, Mahaffey KW, Singer DE, Califf RM, et al. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. European Heart Journal. 35: 1873-80. PMID 24658769 DOI: 10.1093/eurheartj/ehu083  1
2014 Sherwood MW, Douketis JD, Patel MR, Piccini JP, Hellkamp AS, Lokhnygina Y, Spyropoulos AC, Hankey GJ, Singer DE, Nessel CC, Mahaffey KW, Fox KA, Califf RM, Becker RC. Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Circulation. 129: 1850-9. PMID 24552831 DOI: 10.1161/CIRCULATIONAHA.113.005754  1
2014 Sharma R, Macy S, Richardson K, Lokhnygina Y, Laskowitz DT. A blood-based biomarker panel to detect acute stroke. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 23: 910-8. PMID 24119630 DOI: 10.1016/j.jstrokecerebrovasdis.2013.07.034  1
2014 Nicolau JC, Bhatt DL, Roe MT, Lokhnygina Y, Neely B, Corbalán R, Leiva-Pons JL, Martinez F, Goodman SG, Winters KJ, Verheugt FWA, Armstrong PW, White HD, Fox KAA, Prabhakaran D, et al. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial American Heart Journal. DOI: 10.1016/j.ahj.2015.05.017  1
2013 Allen LaPointe NM, Lokhnygina Y, Sanders GD, Peterson ED, Al-Khatib SM. Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation. American Heart Journal. 166: 871-8. PMID 24176443 DOI: 10.1016/j.ahj.2013.08.010  1
2013 Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y, Go AS, Patel MR, Mahaffey KW, Halperin JL, Breithardt G, Hankey GJ, Hacke W, Becker RC, Nessel CC, Fox KA, et al. Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts". Circulation. 128: e172-3. PMID 24019452 DOI: 10.1161/CIRCULATIONAHA.113.004013  1
2013 Bagai A, White JA, Lokhnygina Y, Giugliano RP, Van de Werf F, Montalescot G, Armstrong PW, Tricoci P, Gibson CM, Califf RM, Harrington RA, Newby LK. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome trial. American Heart Journal. 166: 466-73. PMID 24016495 DOI: 10.1016/j.ahj.2013.05.019  1
2013 Wiviott SD, White HD, Ohman EM, Fox KA, Armstrong PW, Prabhakaran D, Hafley G, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, et al. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet (London, England). 382: 605-13. PMID 23953385 DOI: 10.1016/S0140-6736(13)61451-8  1
2013 Piccini JP, White JA, Mehta RH, Lokhnygina Y, Al-Khatib SM, Tricoci P, Califf RM, Harrington RA, Newby LK, Pollack CV, Montalescot G, Van de Werf F, Gibson CM, Giugliano RP. Response to letter regarding article, “sustained ventricular tachycardia and ventricular fibrillation complicating non–ST-segment elevation acute coronary syndromes”. Circulation. 127: e634. PMID 23833786 DOI: 10.1161/CIRCULATIONAHA.112.147546  1
2013 Lopes RD, Lokhnygina Y, Hasselblad V, Newby KL, Yow E, Granger CB, Armstrong PW, Hochman JS, Mills JS, Ruzyllo W, Mahaffey KW. Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy. Trials. 14: 123. PMID 23782531 DOI: 10.1186/1745-6215-14-123  1
2013 Chiu SJ, Lokhnygina Y, Dubis AM, Dubra A, Carroll J, Izatt JA, Farsiu S. Automatic cone photoreceptor segmentation using graph theory and dynamic programming. Biomedical Optics Express. 4: 924-37. PMID 23761854 DOI: 10.1364/BOE.4.000924  1
2013 Singer DE, Hellkamp AS, Piccini JP, Mahaffey KW, Lokhnygina Y, Pan G, Halperin JL, Becker RC, Breithardt G, Hankey GJ, Hacke W, Nessel CC, Patel MR, Califf RM, Fox KA, et al. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial. Journal of the American Heart Association. 2: e000067. PMID 23525418 DOI: 10.1161/JAHA.112.000067  1
2013 Piccini JP, Stevens SR, Lokhnygina Y, Patel MR, Halperin JL, Singer DE, Hankey GJ, Hacke W, Becker RC, Nessel CC, Mahaffey KW, Fox KA, Califf RM, Breithardt G. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial. Journal of the American College of Cardiology. 61: 1998-2006. PMID 23500298 DOI: 10.1016/j.jacc.2013.02.025  1
2013 Leonardi S, Stebbins A, Lopes RD, Lokhnygina Y, Todd M, Bhatt DL, Stone GW, Lincoff AM, Dauerman HL, Gibson CM, White HD, Parikh KH, Gruberg L, Herrmann HC, McLaurin BT, et al. Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial. Coronary Artery Disease. 24: 321-7. PMID 23442944 DOI: 10.1097/MCA.0b013e32835f2fbd  1
2013 Brooks AJ, Lokhnygina Y, Meade CS, Potter JS, Calsyn DA, Greenfield SF. Racial/ethnic differences in the rates and correlates of HIV risk behaviors among drug abusers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 22: 136-47. PMID 23414499 DOI: 10.1111/j.1521-0391.2013.00303.x  1
2013 Patel MR, Hellkamp AS, Lokhnygina Y, Piccini JP, Zhang Z, Mohanty S, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Califf RM, et al. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). Journal of the American College of Cardiology. 61: 651-8. PMID 23391196 DOI: 10.1016/j.jacc.2012.09.057  1
2013 Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y, Go AS, Patel MR, Mahaffey KW, Halperin JL, Breithardt G, Hankey GJ, Hacke W, Becker RC, Nessel CC, Fox KA, et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation. 127: 224-32. PMID 23212720 DOI: 10.1161/CIRCULATIONAHA.112.107128  1
2013 Saxon AJ, Ling W, Hillhouse M, Thomas C, Hasson A, Ang A, Doraimani G, Tasissa G, Lokhnygina Y, Leimberger J, Bruce RD, McCarthy J, Wiest K, McLaughlin P, Bilangi R, et al. Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial. Drug and Alcohol Dependence. 128: 71-6. PMID 22921476 DOI: 10.1016/j.drugalcdep.2012.08.002  1
2013 Ozment CP, Mamo LB, Campbell ML, Lokhnygina Y, Ghio AJ, Turi JL. Transfusion-related biologic effects and free hemoglobin, heme, and iron Transfusion. 53: 732-740. PMID 22882431 DOI: 10.1111/j.1537-2995.2012.03837.x  1
2013 Chan MY, Sun JL, Newby LK, Lokhnygina Y, White HD, Moliterno DJ, Théroux P, Ohman EM, Simoons ML, Mahaffey KW, Pieper KS, Giugliano RP, Armstrong PW, Califf RM, Van de Werf F, et al. Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years. International Journal of Cardiology. 167: 548-54. PMID 22341697 DOI: 10.1016/j.ijcard.2012.01.065  1
2012 Prakalapakorn SG, Freedman SF, Lokhnygina Y, Gandhi NG, Holgado S, Chen BB, El-Dairi MA. Longitudinal reproducibility of optical coherence tomography measurements in children. Journal of Aapos : the Official Publication of the American Association For Pediatric Ophthalmology and Strabismus / American Association For Pediatric Ophthalmology and Strabismus. 16: 523-8. PMID 23237748 DOI: 10.1016/j.jaapos.2012.08.011  1
2012 Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, ... ... Lokhnygina Y, et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. The New England Journal of Medicine. 367: 1297-309. PMID 22920930 DOI: 10.1056/NEJMoa1205512  1
2012 Piccini JP, White JA, Mehta RH, Lokhnygina Y, Al-Khatib SM, Tricoci P, Pollack CV, Montalescot G, Van de Werf F, Gibson CM, Giugliano RP, Califf RM, Harrington RA, Newby LK. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation. 126: 41-9. PMID 22645292 DOI: 10.1161/CIRCULATIONAHA.111.071860  1
2012 Roe MT, White JA, Kaul P, Tricoci P, Lokhnygina Y, Miller CD, van't Hof AW, Montalescot G, James SK, Saucedo J, Ohman EM, Pollack CV, Hochman JS, Armstrong PW, Giugliano RP, et al. Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial. Circulation. Cardiovascular Quality and Outcomes. 5: 205-13. PMID 22373905 DOI: 10.1161/CIRCOUTCOMES.111.962332  1
2012 Mills JS, Mahaffey KW, Lokhnygina Y, Nicolau JC, Ruzyllo W, Adams PX, Todaro TG, Armstrong PW, Granger CB. Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction. Coronary Artery Disease. 23: 118-25. PMID 22217457 DOI: 10.1097/MCA.0b013e32834e4f8f  1
2012 Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, et al. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. The New England Journal of Medicine. 366: 20-33. PMID 22077816 DOI: 10.1056/NEJMoa1109719  1
2012 Jolicœur EM, Sketch MJ, Wojdyla DM, Javaheri SP, Nosib S, Lokhnygina Y, Patel MR, Shaw LK, Tcheng JE. Percutaneous coronary interventions and cardiovascular outcomes for patients with chronic total occlusions. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 79: 603-12. PMID 21805595 DOI: 10.1002/ccd.23269  1
2011 Mahaffey KW, Pieper KS, Lokhnygina Y, Califf RM, Antman EM, Kleiman NS, Goodman SG, White HD, Rao SV, Hochman JS, Cohen M, Col JJ, Roe MT, Ferguson JJ. The impact of postrandomization crossover of therapy in acute coronary syndromes care. Circulation. Cardiovascular Quality and Outcomes. 4: 211-9. PMID 21304094 DOI: 10.1161/CIRCOUTCOMES.109.853598  1
2010 Hursting MJ, Pai PJ, McCracken JE, Hwang F, Suvarna S, Lokhnygina Y, Bandarenko N, Arepally GM. Platelet factor 4/heparin antibodies in blood bank donors. American Journal of Clinical Pathology. 134: 774-80. PMID 20959660 DOI: 10.1309/AJCPG0MNR5NGKNFX  1
2010 Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD, Lokhnygina Y, Kullig U, Göbel U, Capka E, Wiegand J, Schiefke I, Güthoff W, Grüngreiff K, König I, et al. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology. 139: 1586-92, 1592.e1. PMID 20637200 DOI: 10.1053/j.gastro.2010.07.005  1
2010 Chin CT, Roe MT, Fox KA, Prabhakaran D, Marshall DA, Petitjean H, Lokhnygina Y, Brown E, Armstrong PW, White HD, Ohman EM. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. American Heart Journal. 160: 16-22.e1. PMID 20598967 DOI: 10.1016/j.ahj.2010.04.022  1
2010 Brooks A, Meade CS, Potter JS, Lokhnygina Y, Calsyn DA, Greenfield SF. Gender differences in the rates and correlates of HIV risk behaviors among drug abusers. Substance Use & Misuse. 45: 2444-69. PMID 20536356 DOI: 10.3109/10826084.2010.490928  1
2010 Unroe KT, Pfeiffenberger T, Riegelhaupt S, Jastrzembski J, Lokhnygina Y, Colón-Emeric C. Inpatient medication reconciliation at admission and discharge: A retrospective cohort study of age and other risk factors for medication discrepancies. The American Journal of Geriatric Pharmacotherapy. 8: 115-26. PMID 20439061 DOI: 10.1016/j.amjopharm.2010.04.002  1
2010 Califf RM, Lokhnygina Y, Cannon CP, Stepanavage ME, McCabe CH, Musliner TA, Pasternak RC, Blazing MA, Giugliano RP, Harrington RA, Braunwald E. An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design. American Heart Journal. 159: 705-9. PMID 20435175 DOI: 10.1016/j.ahj.2010.03.004  1
2010 Carter-Edwards L, Bastian LA, Revels J, Durham H, Lokhnygina Y, Amamoo MA, Ostbye T. Body image and body satisfaction differ by race in overweight postpartum mothers. Journal of Women's Health (2002). 19: 305-11. PMID 20113143 DOI: 10.1089/jwh.2008.1238  1
2009 Railey MD, Lokhnygina Y, Buckley RH. Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis. The Journal of Pediatrics. 155: 834-840.e1. PMID 19818451 DOI: 10.1016/j.jpeds.2009.07.049  1
2009 Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial). The American Journal of Cardiology. 104: 151-7. PMID 19576338 DOI: 10.1016/j.amjcard.2009.03.020  1
2009 Hofmann AM, Scurlock AM, Jones SM, Palmer KP, Lokhnygina Y, Steele PH, Kamilaris J, Burks AW. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. The Journal of Allergy and Clinical Immunology. 124: 286-91, 291.e1-6. PMID 19477496 DOI: 10.1016/j.jaci.2009.03.045  1
2009 Kandzari DE, Rao SV, Moses JW, Dzavik V, Strauss BH, Kutryk MJ, Simonton CA, Garg J, Lokhnygina Y, Mancini GB, Yeoh E, Buller CE. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial. Jacc. Cardiovascular Interventions. 2: 97-106. PMID 19463409 DOI: 10.1016/j.jcin.2008.10.013  1
2008 Thomas KL, Al-Khatib SM, Lokhnygina Y, Solomon SD, Kober L, McMurray JJ, Califf RM, Velazquez EJ. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality. American Heart Journal. 155: 87-93. PMID 18082495 DOI: 10.1016/j.ahj.2007.09.010  1
2008 Lokhnygina Y, Tsiatis AA. Optimal two-stage group-sequential designs Journal of Statistical Planning and Inference. 138: 489-499. DOI: 10.1016/j.jspi.2007.06.011  1
2007 Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman SG, et al. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Circulation. 116: 2669-77. PMID 18025532 DOI: 10.1161/CIRCULATIONAHA.107.690081  1
2007 Mehta RH, Greenbaum AB, Lokhnygina Y, Newby LK, Van De Werf F, Armstrong PW, Pieper KS, Califf RM, Granger CB, Harrington RA. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials. Journal of Interventional Cardiology. 20: 299-306. PMID 17880325 DOI: 10.1111/j.1540-8183.2007.00277.x  1
2007 Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O'Connor CM, Califf RM, Adams KF. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. European Journal of Heart Failure. 9: 1064-9. PMID 17719273 DOI: 10.1016/j.ejheart.2007.07.011  1
2007 Barnhart HX, Lokhnygina Y, Kosinski AS, Haber M. Comparison of concordance correlation coefficient and coefficient of individual agreement in assessing agreement. Journal of Biopharmaceutical Statistics. 17: 721-38. PMID 17613650 DOI: 10.1080/10543400701329497  1
2007 Lokhnygina Y, Helterbrand JD. Cox regression methods for two-stage randomization designs. Biometrics. 63: 422-8. PMID 17425633 DOI: 10.1111/j.1541-0420.2007.00707.x  1
2007 Niewoehner DE, Lokhnygina Y, Rice K, Kuschner WG, Sharafkhaneh A, Sarosi GA, Krumpe P, Pieper K, Kesten S. Risk indexes for exacerbations and hospitalizations due to COPD. Chest. 131: 20-8. PMID 17218552 DOI: 10.1378/chest.06-1316  1
2007 Sampson UK, Pfeffer MA, McMurray JJ, Lokhnygina Y, White HD, Solomon SD. Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial. European Heart Journal. 28: 685-91. PMID 16984929 DOI: 10.1093/eurheartj/ehl197  1
2007 Hasselblad V, Lokhnygina Y, Krucoff MW. Discussion of: Statistical and regulatory issues with the application of propensity score analysis to nonrandomized medical device clinical studies Journal of Biopharmaceutical Statistics. 17: 19-21. DOI: 10.1080/10543400601044725  1
2007 Hasselblad V, Lokhnygina Y. Tests for 2 × 2 tables in clinical trials Journal of Modern Applied Statistical Methods. 6: 456-468.  1
2006 White HD, Kleiman NS, Mahaffey KW, Lokhnygina Y, Pieper KS, Chiswell K, Cohen M, Harrington RA, Chew DP, Petersen JL, Berdan LG, Aylward PE, Nessel CC, Ferguson JJ, Califf RM. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial. American Heart Journal. 152: 1042-50. PMID 17161049 DOI: 10.1016/j.ahj.2006.08.002  1
2006 Lokhnygina Y. Discussion of the "Executive Summary of the PhRMA Working Group on adaptive designs in clinical drug development" Journal of Biopharmaceutical Statistics. 16: 287-288. DOI: 10.1080/10543400600609684  1
Show low-probability matches.